Cheng PN - Search Results

1

Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.

Harrison SA, Manghi FP, Smith WB, Alpenidze D, Aizenberg D, Klarenbeek N, Chen CY, Zuckerman E, Ravussin E, Charatcharoenwitthaya P, Cheng PN, Katchman H, Klein S, Ben-Ari Z, Mendonza AE, Zhang Y, Martic M, Ma S, Kao S, Tanner S, Pachori A, Badman MK, He Y, Ukomadu C, Sicard E. Harrison SA, et al. Among authors: cheng pn. Nat Med. 2022 Jul;28(7):1432-1438. doi: 10.1038/s41591-022-01861-9. Epub 2022 Jun 20. Nat Med. 2022. PMID: 35725922 Free PMC article. Clinical Trial.

2

High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.

Cheng PN, Jen CM, Young KC, Chen CY, Lu SN, Wang CS, Chang TT. Cheng PN, et al. Hepatogastroenterology. 2003 Mar-Apr;50(50):449-52. Hepatogastroenterology. 2003. PMID: 12749244

3

Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B.

Wu IC, Chow NH, Cheng PN, Liu WC, Young KC, Chang WL, Chen CY, Tseng KC, Chang TT. Wu IC, et al. Among authors: cheng pn. J Med Virol. 2007 Jun;79(6):663-9. doi: 10.1002/jmv.20822. J Med Virol. 2007. PMID: 17457902

4

Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study.

Tseng KC, Chen CY, Tsai HW, Chang TT, Chuang WL, Hsu PI, Liu WC, Cheng PN. Tseng KC, et al. Among authors: cheng pn. Antivir Ther. 2014;19(8):755-64. doi: 10.3851/IMP2754. Epub 2014 Feb 28. Antivir Ther. 2014. PMID: 24583931 Clinical Trial.

5

Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial.

Cheng PN, Liu CJ, Chen CY, Tseng KC, Lo CC, Peng CY, Lin CL, Chiu HC, Chiu YC, Chen PJ. Cheng PN, et al. Clin Gastroenterol Hepatol. 2022 Dec;20(12):2800-2808. doi: 10.1016/j.cgh.2021.11.032. Epub 2021 Dec 2. Clin Gastroenterol Hepatol. 2022. PMID: 34864158 Clinical Trial.

6

Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials.

Wong VW, Tak WY, Goh GBB, Cheng PN, Lawitz EJ, Younossi ZM, Vuppalanchi R, Younes Z, Alkhouri N, Wang L, Liu J, Kersey K, Myers RP, Harrison SA, Goodman Z, Trauner M, Romero-Gomez M, Anstee QM, Nguyen MH, Okanoue T. Wong VW, et al. Among authors: cheng pn. Clin Gastroenterol Hepatol. 2023 Jan;21(1):90-102.e6. doi: 10.1016/j.cgh.2022.01.015. Epub 2022 Jan 22. Clin Gastroenterol Hepatol. 2023. PMID: 35074532 Free article. Clinical Trial.

7

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.

Lin CL, Tai CM, Huang JF, Liu CJ, Chen HF, Cheng PN, Chen CY, Peng CY, Wang CC, Weng SH, Tseng TC, Kao JH. Lin CL, et al. Among authors: cheng pn. J Gastroenterol Hepatol. 2022 Oct;37(10):1901-1910. doi: 10.1111/jgh.15936. Epub 2022 Jul 13. J Gastroenterol Hepatol. 2022. PMID: 35790343

8

Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents.

Cheng PN, Liu WC, Tsai HW, Wu IC, Chang TT, Young KC. Cheng PN, et al. J Med Virol. 2011 Apr;83(4):602-7. doi: 10.1002/jmv.22014. J Med Virol. 2011. PMID: 21328373 Clinical Trial.

9

Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan.

Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH. Liu CH, et al. Among authors: cheng pn. Aliment Pharmacol Ther. 2018 Dec;48(11-12):1290-1300. doi: 10.1111/apt.15011. Epub 2018 Oct 25. Aliment Pharmacol Ther. 2018. PMID: 30362139

10

Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study.

Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH. Liu CH, et al. Among authors: cheng pn. J Formos Med Assoc. 2019 Jun;118(6):1014-1023. doi: 10.1016/j.jfma.2018.10.020. Epub 2018 Nov 15. J Formos Med Assoc. 2019. PMID: 30448077 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page